跳至主要内容
临床试验/NCT01816022
NCT01816022Unknown不适用

Myeloproliferative Neoplasms and Bone Structure

University of Southern Denmark1 个研究点 分布在 1 个国家目标入组 125 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
不适用
入组人数
125
试验地点
1
主要终点
Bone Mineral Density (BMD)

研究概览

简要总结

This is a clinical study to evaluate the effect of CMPN (Chronic myeloproliferative neoplasm) to the bone.

The hypothesis is that patients with CMPN have a higher fracture-rate compared to the background population. We expect to find a lower BMD using conventional DXA scan (dual energy x-ray absorptiometry), and a change in other parameters using HR-pQCT (high-resolution peripheral quantitative computerized tomography).Biochemical bone markers is measured to support the hypothesis.

详细描述

This is a clinical study to evaluate the effect of CMPN to the bone.

Three individual cohorts are defined; a cohort consisting of 50 patients with Polycythemia Vera (PV), a cohort consisting of 50 patients with Essential Thrombocythemia (ET), and a cohort consisting of 25 patients with Primary Myelofibrosis (PMF).

Patients are recruited from the Department of Hematology, Odense University Hospital.

Interventions consist of:

  • Conventional DXA scan to measure Bone Mineral Density (BMD).
  • Experimental HR-pQCT to assess geometry, strength and microstructure of the bone in 3 dimension.
  • Blood-samples are collected and frozen for later analyses of Biochemical Bone Markers: 1-CTP, Ctx, ALP (alkaline phosphatase)and P1NP.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of PV (according to WHO 2008 criteria), only JAK2-pos.(Janus kinase 2)
  • Diagnosis of ET (according to WHO 2008 criteria), only JAK2-pos.
  • Diagnosis of PMF (according to WHO 2008 criteria)independent of JAK2-status.

排除标准

  • Pregnancy
  • Bone Diseases (Mb. Pagets, Myelomatosis, MGUS (monoclonal gammopathy of undetermined significance), osteogenesis imperfecta, Prim. hyperparathyroidism, osteomalacia.
  • Drugs (Prednisone>3 mth, anti-osteoporotic drugs, anti-estrogen drugs.
  • Presence of any psychologic condition or language barrier, which may interfere which a complete understanding, and arise ethnical considerations.

结局指标

主要结局

Bone Mineral Density (BMD)

时间窗: 1 day

Patients will undergo one DXA scan independent of time of CMPN diagnosis

次要结局

  • Evaluation of Geometry, Strength and Micro-Structure of the bone.(1 day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sarah Farmer

MD

University of Southern Denmark

研究点 (1)

Loading locations...

相似试验